Behbahani Ali bought CRSP
August 6, 2025 · Form 4 insider transaction
Behbahani Ali bought 60 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 411 days after the transaction.
Direction
Acquired (buy-side)
Shares
60
Price
$0.00
Total value
N/A
InsiderBehbahani Ali
RoleDirector, 10% owner
SecurityCommon Shares
Transaction codeJ: J
Transaction dateAugust 6, 2025
Filing dateSeptember 21, 2026
Shares owned after316
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
NEA Partners 15, L.P. ("NEA Partners 15") made a pro rata distribution for no consideration of Common Shares of the Issuer to its limited partners on August 6, 2025. The Reporting Person received 60 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025.